Skip to main content

Advertisement

SpringerLink
Log in

Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background/objectives

Few data exist to help physicians in the use of diuretics to provide the greatest symptomatic benefit with the least adverse effect to patients and to select the subset of patients who require a more aggressive diuretic strategy and monitoring. The aim of this study is to identify early predictors of diuretic response in a selected group of patients with acutely decompensated chronic heart failure (ADCHF).

Methods

This was an observational, retrospective secondary analysis of a study including 100 patients with ADCHF.

Results

The mean ± standard deviation (SD) of age was 76.0 ± 10.9 years. Sixty-one patients were female. After three days of inpatient treatment, 16 (16 %) patients maintained or increased i.v. furosemide dose (slow diuretic response, SDR). This group of patients had more indirect signs of fluid overload, including greater body mass index increment. The other 84 patients had greater congestion relief and had decreased i.v. furosemide dose or were switched furosemide to oral route (fast diuretic response, FDR). Admission day factors predicting SDR were: higher levels of pUr (mean ± SD, 69.6 ± 20.9 vs. 52.5 ± 19.8, p = 0.002), higher levels of pUr/pCr ratio (mean ± SD, 58.3 ± 15.2 vs. 49.6 ± 15.1, p = 0.036), higher levels of albuminuria [median (IQR), 131.5 (396.9) vs. 47.1 (143.6), p = 0,011], higher levels of red cell distribution width (RDW) [median (IQR), 16.0 (1.9) vs. 15.1 (1.5), p = 0.039], lower levels of HgB (mean ± SD, 11.5 ± 1.8 vs. 12.6 ± 2.1, p = 0.04) and higher levels of hsTnT [median (IQR), 0.05 (0.05) vs. 0.03 (0.03), p = 0,026]. By multivariate analysis, the strongest independent early predictors of SDR were: pUr [OR (95 % CI), 1.04 [1.01–1.07], p = 0.006] and RDW [OR (95 % CI), 1.47 (1.07–2.02), p = 0.018]. During the first 3 days of hospitalization, the strongest independent factor associated with SDR was NTproBNP increase or decrease by less than 30 % from day 1 to day 3 [OR (95 % CI), 4.84 (1.14–20.55), p = 0.032]. Use of high-dose spironolactone was associated with FDR [OR (95 % CI), 0.17 (0.03–0.85), p = 0.031].

Conclusions

High RDW and high levels of pUr at admission are strong predictors of slower diuretic response. No change or increase in NTproBNP in the first 3 days of treatment is associated with slower diuretic response. On the other hand, the use of high-dose spironolactone is associated with faster diuretic response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gheorghiade M, Pang PS (2009) Acute heart failure syndromes. J Am coll Cardiol 53:557–573 (United States)

    Article  PubMed  Google Scholar 

  2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (hfa) of the ESC. Eur J Heart Fail 14:803–869 (Netherlands)

    Article  PubMed  CAS  Google Scholar 

  3. Albaghdadi M, Gheorghiade M, Pitt B (2011) Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur Heart J 32:2626–2633 (England)

    Article  PubMed  CAS  Google Scholar 

  4. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL (2009) Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE Registry. Cardiology 113:12–19 (Switzerland: 2008 S. Karger AG, Basel)

    Article  PubMed  Google Scholar 

  5. Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, Braunwald E, O’Connor CM, Felker GM (2012) Markers of decongestion, dyspnea relief and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 6:240–245

    Article  PubMed  Google Scholar 

  6. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805

    Article  PubMed  CAS  Google Scholar 

  7. Lindenfeld J, Schrier RW (2011) Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol 58:383–385 (United States)

    Article  PubMed  CAS  Google Scholar 

  8. Felker GM, O’Connor CM, Braunwald E (2009) Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2:56–62

    Article  PubMed  Google Scholar 

  9. Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE (2011) Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol 58:375–382 (United States: 2011 American College of Cardiology Foundation. Published by Elsevier Inc, 2011)

    Article  PubMed  CAS  Google Scholar 

  10. Schrier RW (2008) Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1:2–5 (United States)

    Article  PubMed  CAS  Google Scholar 

  11. Kazory A (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106:694–700 (United States: 2010 Elsevier Inc)

    Article  PubMed  CAS  Google Scholar 

  12. Fenton RA, Knepper MA (2007) Urea and renal function in the 21st century: Insights from knockout mice. J Am Soc Nephrol 18:679–688 (United States)

    Article  PubMed  CAS  Google Scholar 

  13. He XR, Greenberg SG, Briggs JP, Schnermann J (1995) Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension 26:137–142

    Article  PubMed  CAS  Google Scholar 

  14. Martins J, Lourenco P, Araujo JP, Mascarenhas J, Lopes R, Azevedo A, Bettencourt P (2011) Prognostic implications of diuretic dose in chronic heart failure. J Cardiovasc Pharmacol Ther 16:185–191 (United States)

    Article  PubMed  CAS  Google Scholar 

  15. Brisco MA, Coca SG, Chen J, Owens AT, McCauley BD, Kimmel SE, Testani JM (2013) Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 6:233–239 (United States)

    Article  PubMed  CAS  Google Scholar 

  16. Romero Artaza J, Carbia CD, Ceballo MF, Diaz NB (1999) Red cell distribution width (rdw): its use in the characterization of microcytic and hypochromic anemias. Medicina (B Aires) 59:17–22

    CAS  Google Scholar 

  17. Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, Rashid M, Kang S, Weissert S, Coats CJ, Richards T, Thomas M, Woldman S, Okonko DO (2013) Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol. doi:10.1016/j.ijcard.2012.12.091

  18. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sanchez-Mas J, Garrido IP, Valdes M (2009) Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 11:840–846 (Netherlands)

    Article  PubMed  Google Scholar 

  19. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40–47 (United States)

    Article  PubMed  Google Scholar 

  20. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM (2004) Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction–the Hoorn Study. Kidney Int Suppl S42–44 (United States)

  21. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ (2009) Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 374:543–550 (England)

    Article  PubMed  CAS  Google Scholar 

  22. Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L (2010) Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-heart failure trial. Circ Heart Fail 3:65–72 (United States)

    Article  PubMed  CAS  Google Scholar 

  23. Wu AH, Ford L (1999) Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin Chim Acta 284:161–174 (Netherlands)

    Article  PubMed  CAS  Google Scholar 

  24. Mann DL (1999) Mechanisms and models in heart failure: a combinatorial approach. Circulation 100:999–1008

    Article  PubMed  CAS  Google Scholar 

  25. Fonarow GC, Horwich TB (2003) Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 4(Suppl 4):S20–S28

    PubMed  Google Scholar 

  26. Peacock WFt, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH (2008) Cardiac troponin and outcome in acute heart failure. N Engl J Med 358:2117–2126 (United States: 2008 Massachusetts Medical Society)

    Article  PubMed  CAS  Google Scholar 

  27. You JJ, Austin PC, Alter DA, Ko DT, Tu JV (2007) Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153:462–470 (United States)

    Article  PubMed  CAS  Google Scholar 

  28. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:2168–2174 (United States)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the laboratory technicians, especially Mr. Fernando Santos for technical assistance and all the physicians who collaborated in the study.

Conflict of interest

The authors have no conflicts to disclose.

Author information

Authors and Affiliations

  1. Centro Hospitalar do Porto, Porto, Portugal

    João Pedro Ferreira, Mário Santos, Irene Marques & Henrique Carvalho

  2. Climate Change Impacts, Adaptation and Mitigation Research Group (CC-IAM), Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal

    Sofia Almeida

  3. Centro Hospitalar de São João, Porto, Portugal

    Paulo Bettencourt

Authors
  1. João Pedro Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mário Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sofia Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irene Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paulo Bettencourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Henrique Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to João Pedro Ferreira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferreira, J.P., Santos, M., Almeida, S. et al. Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors. Clin Res Cardiol 102, 745–753 (2013). https://doi.org/10.1007/s00392-013-0588-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-013-0588-8

Keywords

Search

Navigation